Teratogen update: Ergot and ergotamine

Gerald V. Raymond

Research output: Contribution to journalArticlepeer-review

29 Scopus citations


Ergotamine is a purified ergot alkaloid that has been suspected of being teratogenicAnimal data have shown effects mainly at doses toxic to the mother. Clinical reports in humans have been anecdotal, but in many the malformations are consistent with vascular injury. However, epidemiologic studies have not shown any clear increase in malformations among exposed infants. This may reflect the limited exposure and toxicity when used episodically. Ergot toxicity which can result in severe vasospasm does not spare the fetus or mother and ergotamine should not be considered without risk. Ergotamine should be avoided in pregnancy, and the counselling of the woman with an exposed fetus should focus on possible toxic exposure. © 1995 WiIey‐Liss, Inc.

Original languageEnglish (US)
Pages (from-to)344-347
Number of pages4
Issue number5
StatePublished - May 1995
Externally publishedYes


Dive into the research topics of 'Teratogen update: Ergot and ergotamine'. Together they form a unique fingerprint.

Cite this